TrialScope’s products and services enable customers to ensure disclosure compliance, maximize trial transparency, improve patient engagement, and accelerate study recruitment.
FREMONT, CA: TrialScope, the global leader in clinical trial transparency, has appointed Chris Venezia as its Chief Commercial Officer in a move to expanding the formers’ executive team. Venezia’s previous roles supported technologies leveraging the power of data, making him the perfect fit for the position. Venezia’s career has been focused mostly on pharmaceutical and healthcare technologies. He worked in global sales at both Clarivate Analytics and Thomson Reuters and was the vice president of sales at GlobalData Plc. A frequent speaker and trainer, he also served as Chief Revenue Officer of Signals Analytics.
“COVID-19 has shined a bright spotlight on the importance of speed and innovation in the drug development process,” said Venezia. “To deliver safe and effective treatments, pharmaceutical companies require patients who trust the clinical trial journey and believe in the treatment’s potential. Accelerating that patient journey will directly lead to novel breakthroughs, and transparency of trial information is where it all starts. That’s why joining TrialScope was an easy decision for me.”
TrialScope unlocks clinical trial data superpowers. The TrialScope Transparency CloudTM makes centralizing, structuring, and activating clinical trial information simple, for use across the organization and at every stage of the study. Their integrated platform is used by 16 of the top 20 clinical trial sponsors in the world. They rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement, and accelerate study recruitment. The firm was also selected as one of the “Top 25 Life Sciences Technology Vendors” by CIO Applications Magazine in 2017.
“We are excited to add someone of Chris’s caliber to our team,” said TrialScope CEO Jeff Kozloff. “With his guidance, we will continue to ensure our sponsors are compliant with global disclosure regulations and give their trial data superpowers throughout the lifecycle of the trial and across the organization.”
In the future, Venezia predicts clinical trial transparency will be one of the most critical factors in advancing medical science. A big part of that is connecting more patients with clinical research, he adds.